课题基金 / 基金详情

The mechanism of Tat-enhanced reverse transcription in HIV-1

The mechanism of Tat-enhanced reverse transcription in HIV-1
HIV-1中Tat增强逆转录的机制
批准号:
nhmrc : 252846
负责人:
A/Pr David Harrich
金额:
$18.85万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2003
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2003-01-01 至 2005-12-31

项目摘要

项目成果

A/Pr David Harrich的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
During reverse transcription, the positive-strand HIV-1 RNA genome is converted into a double-stranded DNA copy which can be permanently insert into the host cell genome. Many HIV-1 proteins including Tat contribute to the efficiency of reverse transcription. There are two competing hypotheses to explain how Tat enhances reverse transcription. The indirect mechanism hypothesis holds that Tat-enhanced reverse transcription is due to the combined effects of the Tat-induced expression of cellular genes. The direct mechanism hypothesis is that Tat functions directly during RTN, implying it is a virion protein. Our recent genetic and biochemical data provide strong evidence that a novel form of Tat, which we call vTat, has a direct role in RTN. This proposal will investigate these two leading hypotheses. Given the enormity of the HIV pandemic and the many recent reports from the United States that most patient isolated virus is resistant to at least one antiretroviral drug, these studies have as an outcome the identification and characterisation of important new key molecules towards which antiretroviral strategies can be designed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
  • 批准号:
    nhmrc : GNT1085359
  • 项目类别:
    Project Grants
  • 资助金额:
    $110.11万
  • 财政年份:
    2015
  • 负责人:
    A/Pr David Harrich
  • 依托单位:
eEF1A1 is critical for HIV-1 reverse transcription and replication
The Human Eukaryotic Translation Elongation Factor 1A is a Paramyxovirus Virus Dependency Factor
国内基金
海外基金
可注射磁性Xc-T转运体抑制剂介导铁死亡协同TAT增敏自噬共同崩解“肿瘤抗氧化效应”治疗TNBC
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    梁冰
  • 依托单位:
AIBP通过逆转HIV-1 tat调控的线粒体自噬障碍减少HAND发生的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    严玉娟
  • 依托单位:
TAT-CHIP 融合蛋白减轻脓毒症心功能障碍的作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    吴森泉
  • 依托单位:
AS1411适体/TAT透膜肽引导的核靶向分子探针及肿瘤细胞核中DNA修复酶原位成像研究
  • 批准号:
    82403694
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2024
  • 负责人:
    李伟
  • 依托单位: